PTPN2 and cancer: Furthermore, loss of PTPN2 in patients with triple-negative breast cancer was associated with poor response to tamoxifen (40, 41) demonstrating the relevance of this phosphatase to the response of human cancer to chemotherapy in addition to immunotherapy.